228 related articles for article (PubMed ID: 29039578)
21. FoxM1 drives ADAM17/EGFR activation loop to promote mesenchymal transition in glioblastoma.
Zhang C; Han X; Xu X; Zhou Z; Chen X; Tang Y; Cheng J; Moazzam NF; Liu F; Xu J; Peng W; Du F; Zhang B; Song Z; Zeng J; Gong A
Cell Death Dis; 2018 May; 9(5):469. PubMed ID: 29700308
[TBL] [Abstract][Full Text] [Related]
22. RETRACTED: Serine/threonine kinase BUB1 promotes proliferation and radio-resistance in glioblastoma.
Yu H; Zhang S; Ibrahim AN; Deng Z; Wang M
Pathol Res Pract; 2019 Aug; 215(8):152508. PubMed ID: 31272759
[TBL] [Abstract][Full Text] [Related]
23. TRIP13 promotes the cell proliferation, migration and invasion of glioblastoma through the FBXW7/c-MYC axis.
Zhang G; Zhu Q; Fu G; Hou J; Hu X; Cao J; Peng W; Wang X; Chen F; Cui H
Br J Cancer; 2019 Dec; 121(12):1069-1078. PubMed ID: 31740732
[TBL] [Abstract][Full Text] [Related]
24. E2F transcription factor 8 promotes proliferation and radioresistance in glioblastoma.
Yu H; Zhang D; Li Z; Wang M
Pathol Res Pract; 2020 Aug; 216(8):153030. PubMed ID: 32703494
[TBL] [Abstract][Full Text] [Related]
25. A lignan from Alnus japonica inhibits glioblastoma tumorspheres by suppression of FOXM1.
Shim JK; Lim SH; Jeong JH; Choi RJ; Oh Y; Park J; Choi S; Hong J; Kim SJ; Moon JH; Kim EH; Teo WY; Park BJ; Chang JH; Ryu JH; Kang SG
Sci Rep; 2022 Aug; 12(1):13990. PubMed ID: 35978012
[TBL] [Abstract][Full Text] [Related]
26. Knockdown of
Zeng Q; Zhang S; He L; Fu Q; Liao L; Chen L; Ding X
Cancer Biother Radiopharm; 2024 Apr; 39(3):236-246. PubMed ID: 37782908
[No Abstract] [Full Text] [Related]
27. microRNAs: Potential glioblastoma radiosensitizer by targeting radiation-related molecular pathways.
Bahreyni-Toossi MT; Dolat E; Khanbabaei H; Zafari N; Azimian H
Mutat Res; 2019 Nov; 816-818():111679. PubMed ID: 31715522
[TBL] [Abstract][Full Text] [Related]
28. Increased BUB1B/BUBR1 expression contributes to aberrant DNA repair activity leading to resistance to DNA-damaging agents.
Komura K; Inamoto T; Tsujino T; Matsui Y; Konuma T; Nishimura K; Uchimoto T; Tsutsumi T; Matsunaga T; Maenosono R; Yoshikawa Y; Taniguchi K; Tanaka T; Uehara H; Hirata K; Hirano H; Nomi H; Hirose Y; Ono F; Azuma H
Oncogene; 2021 Oct; 40(43):6210-6222. PubMed ID: 34545188
[TBL] [Abstract][Full Text] [Related]
29. Glioblastoma multiforme formation and EMT: role of FoxM1 transcription factor.
Wang Z; Zhang S; Siu TL; Huang S
Curr Pharm Des; 2015; 21(10):1268-71. PubMed ID: 25506897
[TBL] [Abstract][Full Text] [Related]
30. HDAC4 and HDAC6 sustain DNA double strand break repair and stem-like phenotype by promoting radioresistance in glioblastoma cells.
Marampon F; Megiorni F; Camero S; Crescioli C; McDowell HP; Sferra R; Vetuschi A; Pompili S; Ventura L; De Felice F; Tombolini V; Dominici C; Maggio R; Festuccia C; Gravina GL
Cancer Lett; 2017 Jul; 397():1-11. PubMed ID: 28342984
[TBL] [Abstract][Full Text] [Related]
31. PLK3 promotes the proneural-mesenchymal transition in glioblastoma via transcriptional regulation of C5AR1.
Yu S; Lv L; Li Y; Ning Q; Liu T; Hu T
Mol Biol Rep; 2023 Oct; 50(10):8249-8258. PubMed ID: 37568042
[TBL] [Abstract][Full Text] [Related]
32. BUB1B and circBUB1B_544aa aggravate multiple myeloma malignancy through evoking chromosomal instability.
Tang X; Guo M; Ding P; Deng Z; Ke M; Yuan Y; Zhou Y; Lin Z; Li M; Gu C; Gu X; Yang Y
Signal Transduct Target Ther; 2021 Oct; 6(1):361. PubMed ID: 34620840
[TBL] [Abstract][Full Text] [Related]
33. Metabolic modulation of histone acetylation mediated by HMGCL activates the FOXM1/β-catenin pathway in glioblastoma.
Sun Y; Mu G; Zhang X; Wu Y; Wang S; Wang X; Xue Z; Wang C; Liu J; Li W; Zhang L; Guo Y; Zhao F; Liu X; Xue Z; Zhang Y; Ni S; Wang J; Li X; Han M; Huang B
Neuro Oncol; 2024 Apr; 26(4):653-669. PubMed ID: 38069906
[TBL] [Abstract][Full Text] [Related]
34. Flavopiridol Suppresses Cell Proliferation and Migration and Induces Apoptotic Cell Death by Inhibiting Oncogenic FOXM1 Signaling in IDH Wild-Type and IDH-Mutant GBM Cells.
Guler A; Hamurcu Z; Ulutabanca H; Cınar V; Nurdinov N; Erdem S; Ozpolat B
Mol Neurobiol; 2024 Feb; 61(2):1061-1079. PubMed ID: 37676393
[TBL] [Abstract][Full Text] [Related]
35. Bioinformatics Analysis Reveals FOXM1/BUB1B Signaling Pathway as a Key Target of Neosetophomone B in Human Leukemic Cells: A Gene Network-Based Microarray Analysis.
Kuttikrishnan S; Masoodi T; Sher G; Bhat AA; Patil K; El-Elimat T; Oberlies NH; Pearce CJ; Haris M; Ahmad A; Alali FQ; Uddin S
Front Oncol; 2022; 12():929996. PubMed ID: 35847923
[TBL] [Abstract][Full Text] [Related]
36. Phenethyl isothiocyanate alters the gene expression and the levels of protein associated with cell cycle regulation in human glioblastoma GBM 8401 cells.
Chou YC; Chang MY; Wang MJ; Liu HC; Chang SJ; Harnod T; Hung CH; Lee HT; Shen CC; Chung JG
Environ Toxicol; 2017 Jan; 32(1):176-187. PubMed ID: 26678675
[TBL] [Abstract][Full Text] [Related]
37. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.
Hamurcu Z; Ashour A; Kahraman N; Ozpolat B
Oncotarget; 2016 Mar; 7(13):16619-35. PubMed ID: 26918606
[TBL] [Abstract][Full Text] [Related]
38. USP21 regulates Hippo signaling to promote radioresistance by deubiquitinating FOXM1 in cervical cancer.
Li Z; Liu X; Yu H; Wang S; Zhao S; Jiang G
Hum Cell; 2022 Jan; 35(1):333-347. PubMed ID: 34825342
[TBL] [Abstract][Full Text] [Related]
39. The proneural gene ASCL1 governs the transcriptional subgroup affiliation in glioblastoma stem cells by directly repressing the mesenchymal gene NDRG1.
Narayanan A; Gagliardi F; Gallotti AL; Mazzoleni S; Cominelli M; Fagnocchi L; Pala M; Piras IS; Zordan P; Moretta N; Tratta E; Brugnara G; Altabella L; Bozzuto G; Gorombei P; Molinari A; Padua RA; Bulfone A; Politi LS; Falini A; Castellano A; Mortini P; Zippo A; Poliani PL; Galli R
Cell Death Differ; 2019 Sep; 26(9):1813-1831. PubMed ID: 30538287
[TBL] [Abstract][Full Text] [Related]
40. Peroxiredoxin II promotes hepatic tumorigenesis through cooperation with Ras/Forkhead box M1 signaling pathway.
Park YH; Kim SU; Kwon TH; Kim JM; Song IS; Shin HJ; Lee BK; Bang DH; Lee SJ; Lee DS; Chang KT; Kim BY; Yu DY
Oncogene; 2016 Jul; 35(27):3503-13. PubMed ID: 26500057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
